Drug to stop cancer from spreading developed

Image
IANS New York
Last Updated : Jun 22 2018 | 6:10 PM IST

Scientists have developed a drug compound that may freeze cancer cells and kill them, thus keeping them from spreading throughout the body.

The study found that the compound named KBU2046 is highly effective and can slow down cell motility in the cancers of breast, prostate, colon and lungs in the in vitro model.

"Movement is key: the difference is black and white, night and day. If cancer cells spread throughout your body, they will take your life. We can treat it, but it will take your life," said Raymond Bergan from Oregon Health and Science University (OHSU) in the US.

"We used chemistry to probe biology to give us a perfect drug that would only inhibit the movement of cancer cells and wouldn't do anything else. That basic change in logic lead us to do everything we did."

In the study, published in the journal Nature Communications, the team used a mouse model to test the drug.

"We started off with a chemical that stopped cells from moving, then we increasingly refined that chemical until it did a perfect job of stopping the cells with no side effects," Bergan said.

The team found that the key to this drug was engaging the heat shock proteins -- the "cleaners" of a cell.

"The way the drug works is that it binds to these cleaner proteins to stop cell movement, but it has no other effect on those proteins," Bergan said.

"Our eventual goal is to be able to say to a woman with breast cancer: here, take this pill and your cancer won't spread throughout your body. The same thing for patients with prostate, lung, and colon cancer."

The team will now move this forward as a therapy to test in humans.

--IANS

sh/rt/him/vd

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 22 2018 | 6:04 PM IST

Next Story